ABT
NYSE
Health Care
$95.63
USD
+$0.23 (+0.24%)
At close: Jul 6, 2026, 4:00 PM EDT
Market Cap:
$164.67B
Volume:
14M
Previous Close
$95.40
Day Range
$92.99 - $95.92
52 Week Range
$81.97 - $137.49
Average Volume (10 Days)
15.7M
P/E Ratio
25.24
Dividend Yield
2.54%
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 115,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
CEO
Mr. Robert Ford
Headquaters
ABBOTT PARK, ILLINOIS, US
Founded
1937
Employees
115,000
Abbott Laboratories was ordered to pay $70 million after a Cook County jury found its Similac formula contributed to necrotizing enterocolitis (NEC) in four premature infants. Plaintiffs argued Abbott knew of the risks but failed to warn parents adequately. This marks the latest loss for Abbott in state court amid thousands of similar lawsuits, though the company has succeeded in federal cases and vowed to appeal.
0
1
SYK
Stryker Corp
$324.73
-0.6%